AXSM: Axsome Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Axsome Therapeutics Inc (AXSM).
$4.10B Market Cap.
AXSM Market Cap. (MRY)
AXSM Shares Outstanding (MRY)
AXSM Assets (MRY)
Total Assets
$568.50M
Total Liabilities
$511.48M
Total Investments
$0
AXSM Income (MRY)
Revenue
$385.69M
Net Income
-$287.22M
Operating Expense
$632.95M
AXSM Cash Flow (MRY)
CF Operations
-$128.41M
CF Investing
-$270.00K
CF Financing
$57.84M
AXSM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $568,498,000 (-3.36%) | $588,236,000 (77.46%) | $331,476,000 (277.60%) | $87,785,058 (-52.84%) |
Assets Current | $485,064,000 (-3.81%) | $504,263,000 (105.28%) | $245,642,000 (183.92%) | $86,518,140 (-52.99%) |
Assets Non-Current | $83,434,000 (-0.64%) | $83,973,000 (-2.17%) | $85,834,000 (6675.02%) | $1,266,918 (-39.94%) |
Goodwill & Intangible Assets | $58,936,000 (-9.78%) | $65,328,000 (-6.64%) | $69,971,000 (0%) | $0 (0%) |
Shareholders Equity | $57,015,000 (-70.15%) | $190,977,000 (74.32%) | $109,556,000 (600.92%) | $15,630,352 (-86.26%) |
Property Plant & Equipment Net | $5,967,000 (-21.67%) | $7,618,000 (567.08%) | $1,142,000 (20.97%) | $944,008 (-47.32%) |
Cash & Equivalents | $315,353,000 (-18.34%) | $386,193,000 (92.29%) | $200,842,000 (132.26%) | $86,472,854 (-52.97%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $15,732,000 (3.94%) | $15,135,000 (250.35%) | $4,320,000 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $142,001,000 (49.76%) | $94,820,000 (151.52%) | $37,699,000 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $71,997,000 (76.99%) | $40,679,000 (5.37%) | $38,605,000 (193.59%) | $13,149,329 (-2.63%) |
Accumulated Retained Earnings (Deficit) | -$1,122,787,000 (-34.37%) | -$835,571,000 (-40.12%) | -$596,333,000 (-45.73%) | -$409,199,085 (-46.77%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $191,534,000 (2.77%) | $186,372,000 (96.84%) | $94,684,000 (90.47%) | $49,710,197 (-0.83%) |
Debt Current | $1,835,000 (44.83%) | $1,267,000 (198.12%) | $425,000 (-31.53%) | $620,675 (-49.15%) |
Debt Non-Current | $189,699,000 (2.48%) | $185,105,000 (96.38%) | $94,259,000 (92.01%) | $49,089,522 (0.38%) |
Total Liabilities | $511,483,000 (28.75%) | $397,259,000 (79.01%) | $221,920,000 (207.56%) | $72,154,706 (-0.26%) |
Liabilities Current | $230,104,000 (65.72%) | $138,854,000 (43.80%) | $96,561,000 (318.64%) | $23,065,184 (-1.59%) |
Liabilities Non-Current | $281,379,000 (8.89%) | $258,405,000 (106.13%) | $125,359,000 (155.37%) | $49,089,522 (0.38%) |
AXSM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $385,693,000 (42.53%) | $270,600,000 (440.80%) | $50,037,000 (0%) | $0 (0%) |
Cost of Revenue | $33,303,000 (27.77%) | $26,065,000 (401.44%) | $5,198,000 (0%) | $0 (0%) |
Selling General & Administrative Expense | $411,359,000 (27.31%) | $323,123,000 (102.90%) | $159,254,000 (138.95%) | $66,646,205 (130.64%) |
Research & Development Expense | $187,077,000 (91.00%) | $97,944,000 (69.02%) | $57,947,000 (-0.20%) | $58,060,725 (-17.34%) |
Operating Expenses | $632,952,000 (32.87%) | $476,360,000 (112.06%) | $224,638,000 (80.13%) | $124,706,930 (25.79%) |
Interest Expense | $6,569,000 (1.80%) | $6,453,000 (-12.02%) | $7,335,000 (28.77%) | $5,696,062 (122.00%) |
Income Tax Expense | $85,000 (-91.15%) | $960,000 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$287,216,000 (-20.05%) | -$239,238,000 (-27.84%) | -$187,134,000 (-43.50%) | -$130,402,992 (-26.73%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$287,216,000 (-20.05%) | -$239,238,000 (-27.84%) | -$187,134,000 (-43.50%) | -$130,402,992 (-26.73%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$287,216,000 (-20.05%) | -$239,238,000 (-27.84%) | -$187,134,000 (-43.50%) | -$130,402,992 (-26.73%) |
Weighted Average Shares | $47,914,253 (5.48%) | $45,425,212 (11.73%) | $40,655,941 (8.07%) | $37,618,599 (1.11%) |
Weighted Average Shares Diluted | $47,914,253 (5.48%) | $45,425,212 (11.73%) | $40,655,941 (8.07%) | $37,618,599 (1.11%) |
Earning Before Interest & Taxes (EBIT) | -$280,562,000 (-21.02%) | -$231,825,000 (-28.94%) | -$179,799,000 (-44.18%) | -$124,706,930 (-24.22%) |
Gross Profit | $352,390,000 (44.11%) | $244,535,000 (445.36%) | $44,839,000 (0%) | $0 (0%) |
Operating Income | -$280,562,000 (-21.02%) | -$231,825,000 (-28.94%) | -$179,799,000 (-44.18%) | -$124,706,930 (-25.79%) |
AXSM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$270,000 (53.61%) | -$582,000 (98.92%) | -$53,702,000 (-17335.71%) | -$308,000 (-571.16%) |
Net Cash Flow from Financing | $57,840,000 (-82.53%) | $331,013,000 (16.32%) | $284,582,000 (2456.89%) | $11,130,000 (-73.76%) |
Net Cash Flow from Operations | -$128,410,000 (11.49%) | -$145,080,000 (-24.52%) | -$116,511,000 (-7.66%) | -$108,226,000 (-37.94%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$70,840,000 (-138.22%) | $185,351,000 (62.06%) | $114,369,000 (217.42%) | -$97,404,000 (-169.89%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$53,000,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$270,000 (53.61%) | -$582,000 (17.09%) | -$702,000 (-127.92%) | -$308,000 (-571.16%) |
Issuance (Repayment) of Debt Securities | -$990,000 (-101.18%) | $83,558,000 (87.72%) | $44,513,000 (14505.50%) | -$309,000 (-101.13%) |
Issuance (Purchase) of Equity Shares | $71,464,000 (-73.65%) | $271,169,000 (8.46%) | $250,014,000 (2011.96%) | $11,838,000 (-21.99%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $85,218,000 (36.09%) | $62,620,000 (65.99%) | $37,726,000 (81.35%) | $20,803,000 (40.98%) |
Depreciation Amortization & Accretion | $9,346,000 (12.82%) | $8,284,000 (48.89%) | $5,564,000 (381.73%) | $1,155,000 (1386.14%) |
AXSM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 91.40% (1.11%) | 90.40% (0.89%) | 89.60% | - |
Profit Margin | -74.50% (15.72%) | -88.40% (76.36%) | -374.00% | - |
EBITDA Margin | -70.30% (14.89%) | -82.60% (76.28%) | -348.20% | - |
Return on Average Equity (ROAE) | -289.50% (-157.56%) | -112.40% (55.43%) | -252.20% (-9.32%) | -230.70% (-213.45%) |
Return on Average Assets (ROAA) | -51.70% (-18.31%) | -43.70% (45.17%) | -79.70% (21.40%) | -101.40% (-91.68%) |
Return on Sales (ROS) | -72.70% (15.17%) | -85.70% (76.15%) | -359.30% | - |
Return on Invested Capital (ROIC) | -161.80% (-16.82%) | -138.50% (52.88%) | -293.90% (32.12%) | -433.00% (46.09%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -14.13 (6.47%) | -15.1 (9.93%) | -16.77 (-54.00%) | -10.89 (62.98%) |
Price to Sales Ratio (P/S) | 10.51 (-21.33%) | 13.36 (-78.68%) | 62.67 | - |
Price to Book Ratio (P/B) | 71.92 (264.68%) | 19.72 (-35.50%) | 30.57 (-66.44%) | 91.1 (240.74%) |
Debt to Equity Ratio (D/E) | 8.97 (331.30%) | 2.08 (2.67%) | 2.03 (-56.11%) | 4.62 (625.79%) |
Earnings Per Share (EPS) | -5.99 (-13.66%) | -5.27 (-14.57%) | -4.6 (-32.56%) | -3.47 (-25.27%) |
Sales Per Share (SPS) | 8.05 (35.14%) | 5.96 (383.92%) | 1.23 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.69 (16.25%) | -3.21 (-11.24%) | -2.88 (0.07%) | -2.88 (-36.73%) |
Book Value Per Share (BVPS) | 1.19 (-71.69%) | 4.2 (55.99%) | 2.69 (549.40%) | 0.41 (-86.43%) |
Tangible Assets Book Value Per Share (TABVPS) | 10.63 (-7.61%) | 11.51 (78.96%) | 6.43 (175.58%) | 2.33 (-53.35%) |
Enterprise Value Over EBIT (EV/EBIT) | -14 (6.67%) | -15 (16.67%) | -18 (-63.64%) | -11 (62.07%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -14.62 (7.58%) | -15.81 (14.33%) | -18.46 (-67.76%) | -11 (61.78%) |
Asset Turnover | 0.69 (40.49%) | 0.49 (131.92%) | 0.21 (0%) | 0 (0%) |
Current Ratio | 2.11 (-41.96%) | 3.63 (42.77%) | 2.54 (-32.18%) | 3.75 (-52.23%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$128,680,000 (11.66%) | -$145,662,000 (-24.27%) | -$117,213,000 (-8.00%) | -$108,534,000 (-38.26%) |
Enterprise Value (EV) | $3,964,080,633 (12.13%) | $3,535,173,746 (9.92%) | $3,216,269,692 (136.59%) | $1,359,424,605 (-52.93%) |
Earnings Before Tax (EBT) | -$287,131,000 (-20.50%) | -$238,278,000 (-27.33%) | -$187,134,000 (-43.50%) | -$130,402,992 (-26.66%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$271,216,000 (-21.33%) | -$223,541,000 (-28.30%) | -$174,235,000 (-41.02%) | -$123,551,930 (-23.17%) |
Invested Capital | $155,639,000 (-15.52%) | $184,233,000 (213.40%) | $58,786,000 (110.27%) | $27,957,217 (-3.41%) |
Working Capital | $254,960,000 (-30.23%) | $365,409,000 (145.11%) | $149,081,000 (134.95%) | $63,452,956 (-60.49%) |
Tangible Asset Value | $509,562,000 (-2.55%) | $522,908,000 (99.96%) | $261,505,000 (197.89%) | $87,785,058 (-52.84%) |
Market Capitalization | $4,100,401,633 (8.87%) | $3,766,162,746 (12.44%) | $3,349,459,875 (135.22%) | $1,423,993,673 (-53.20%) |
Average Equity | $99,200,250 (-53.38%) | $212,775,250 (186.74%) | $74,203,706 (31.29%) | $56,519,504 (-59.59%) |
Average Assets | $555,977,500 (1.55%) | $547,477,500 (133.08%) | $234,888,282 (82.60%) | $128,638,042 (-33.91%) |
Invested Capital Average | $173,449,000 (3.62%) | $167,389,750 (173.65%) | $61,169,703 (112.39%) | $28,800,080 (130.42%) |
Shares | 48,462,376 (2.42%) | 47,319,547 (8.97%) | 43,426,162 (15.21%) | 37,691,733 (0.93%) |
